pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Preclinical
    RAP-103
    Dementia Associated With Alzheimer's Disease Creative Bio-Peptides Inc
  • Phase 2
    RAP-219
    Bipolar I Disorder$RAPP Rapport Therapeutics, Inc.
  • Phase 2
    RAPA-201
    Refractory Multiple Myeloma Rapa Therapeutics LLC
  • Phase 2
← prev
page 147 of 271
next →
Pain89
Neurology1
RB-601
Head And Neck Cancer
Radiance Biopharma Inc
  • Preclinical
    RBIO-101
    no indication Reflection Biotechnologies Ltd
  • Phase 1
    RBM-001
    Coronavirus Disease 2019 (COVID-19) Rock Biomedical Inc
  • Phase 1
    RCI-001
    Keratoconjunctivitis Sicca (Dry Eye) Rudacure Co Ltd
  • Phase 1
    RCT-1100
    Primary Ciliary Dyskinesia Recode Therapeutics Inc
  • Phase 2
    RCT-2100
    Cystic Fibrosis Recode Therapeutics Inc
  • Phase 2
    RD-1302
    T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphobla… Imviva Biotech
  • Preclinical
    RDX-10531
    Unspecified$ARDX ARDELYX, INC.
  • REBLOZYL
    REBLOZYL (LUSPATERCEPT-AAMT)
    no indication Celgene Corp
  • Phase 2
    REC-1245
    Lymphoma$RXRX RECURSION PHARMACEUTICALS, INC.
  • Phase 1
    REC-4539
    Gastric Cancer$RXRX RECURSION PHARMACEUTICALS, INC.
  • Phase 2
    REC-4881
    Familial Adenomatous Polyposis$RXRX RECURSION PHARMACEUTICALS, INC.
  • RECARBRIO
    RECARBRIO (CILASTATIN SODIUM)
    1 INDICATIONS AND USAGE RECARBRIO is a combination of imi…$MRK Merck & Co., Inc.
  • Preclinical
    RECCE-529
    Coronavirus Disease 2019 (COVID-19) Recce Pharmaceuticals Ltd
  • RECLAST
    RECLAST (ZOLEDRONIC ACID)
    no indication Sandoz Inc
  • REDEMPLO
    REDEMPLO (PLOZASIRAN SODIUM)
    1 INDICATIONS AND USAGE REDEMPLO is indicated as an adjun…$ARWR ARROWHEAD PHARMACEUTICALS, INC.
  • REGADENOSON
    REGADENOSON
    no indication APOTEX
  • Marketed
    REGLAN
    REGLAN (METOCLOPRAMIDE HYDROCHLORIDE)
    Diabetic Gastroparesis$ANIP ANI PHARMACEUTICALS INC
  • Phase 2
    REGV-131
    Hemophilia B (Factor IX Deficiency)$REGN REGENERON PHARMACEUTICALS, INC.
  • Phase 2
    REM-422
    Adenoid Cystic Carcinoma (ACC) Remix Therapeutics Inc
  • RENACIDIN
    RENACIDIN (CITRIC ACID, GLUCONOLACTONE AND MAGNESIUM CARBONATE)
    no indication UNITED GUARDIAN
  • RENFLEXIS
    RENFLEXIS (INFLIXIMAB-ABDA)
    no indication Samsung Bioepis Co Ltd
  • Preclinical
    REP-0003
    Homozygous Familial Hypercholesterolemia (HoFH) Repair Biotechnologies Inc
  • Phase 3
    RESCAP
    Acute Renal Failure (ARF) (Acute Kidney Injury) Alloksys Life Sciences BV
  • RETEVMO
    RETEVMO (SELPERCATINIB)
    1 INDICATIONS AND USAGE RETEVMO ® is a kinase inhibitor i…$LLY ELI LILLY & Co
  • Preclinical
    REV-0100
    Juvenile Macular Degeneration (Stargardt Disease) ReVision Therapeutics Inc
  • Phase 2
    REVTX-300
    Chronic Kidney Disease (Chronic Renal Failure)$REVB REVELATION BIOSCIENCES, INC.